for HD Chorea in Adults

Go about
your day
with reduced
uncontrollable movements

People taking AUSTEDO®
(deutetrabenazine) tablets saw

With AUSTEDO there was more than twice the reduction in Huntington’s Disease chorea at 12 weeks compared to placebo

in Huntington’s disease (HD) chorea
vs placebo in a 12-week study*

*4.4-point improvement in people taking AUSTEDO vs 1.9 in people taking placebo based on Total Maximal Chorea
(TMC) score. The TMC score is used to measure HD chorea movements in the face, mouth, trunk, both arms,
and both legs.

In clinical trials

93% of adults continued taking AUSTEDO without needing to reduce their dose due to side effects

continued taking AUSTEDO without
needing to reduce their dose due to side effects

Established safety results for

ESTABLISHED SAFETY RESULTS FOR ABOUT 3 YEARS

†This was an open-label study, which is a drug trial in which all participants are aware of the drug being tested.

9 out of 10 people on AUSTEDO XR said their movement control had improved since starting treatment

said their movement control had improved since starting treatment‡

‡Results from a real-world survey including 31 patients with HD chorea taking AUSTEDO XR.

Once-daily AUSTEDO XR contains the same active
ingredient as twice-daily AUSTEDO. Data on this page is
based on twice-daily dosing.

Due to reduced uncontrollable movements, people taking AUSTEDO reported improvements in other aspects of everyday life.§

66% icon

66%

of people

Reported improvements in:

Social lives

  • Ability to spend time with family and friends
  • Ability to leave the house
  • Relationship with partner or children
71% icon

71%

of people

Reported improvements in:

Emotional
well-being

  • Feeling more hopeful
  • Feeling less embarrassed
  • Feeling less judged
67% icon

Up to

67%

of people

Reported improvements in:

Ability to complete
everyday tasks

  • Less sleep disruptions
  • Easier to dress or care for themselves
  • Easier to eat and take medications
  • Easier to hold objects
71% icon

Up to

71%

of people

Reported improvements in:

Work lives
and hobbies

  • Easier to drive or take public transit
  • Ability to work or go to school
  • Easier to write, type, or use a computer/mobile device
  • Easier to participate in fun activities
§Results from a real-world survey including 192 people with HD and 233 care partners. Once-daily AUSTEDO XR contains the same active ingredient
as twice-daily AUSTEDO. Survey participants were asked about AUSTEDO in reference to both products.

People taking AUSTEDO XR were more physically capable of performing everyday tasks, allowing them to stay independent longer.

  • Climbing stairs
  • Bending, kneeling, or stooping
  • Lifting/carrying groceries
  • Walking
  • Dressing
  • Bathing
  • Moderate to vigorous activities
People taking AUSTEDO XR were more physically capable of performing everyday tasks

People taking AUSTEDO achieved greater improvement in the SF-36∥ Physical Functioning Score at 12 weeks vs placebo.

See study details

∥SF-36=36-Item Short Form Health Survey assessing health-related quality of life.

AUSTEDO XR/AUSTEDO does not cure the
cause of the uncontrollable movements and it does
not treat the other symptoms of HD, such
as problems with thinking or emotions.

See why Ray and Rhonda made the decision to treat HD chorea.

See why Ray and Rhonda made the decision to treat HD chorea

When HD chorea threatened to disrupt Ray and Rhonda’s retirement plans, they knew it was time to ask Ray’s healthcare provider about treatment options.

Living with HD chorea

Chorea can be one of the most frustrating symptoms for people with HD and the people who care for them, impacting daily life and relationships.

Learn more

Start the
conversation now

Whether you’re starting to plan ahead or
considering medication,
using the Appointment Preparation Guide to talk to a healthcare

provider is an important step.

Get the guide